Addenbrooke's Hospital, Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom.
S.H. Ho Urology Centre, Department of Surgery, The Chinese University of Hong Kong, Hong Kong, China.
Urol Oncol. 2021 Jul;39(7):379-399. doi: 10.1016/j.urolonc.2021.03.012. Epub 2021 May 20.
There continues to be rapid developments and research in the field of Artificial Intelligence (AI) in Urological Oncology worldwide. In this review we discuss the basics of AI, application of AI per tumour group (Renal, Prostate and Bladder Cancer) and application of AI in Robotic Urological Surgery. We also discuss future applications of AI being developed with the benefits to patients with Urological Oncology.
在全球范围内，人工智能（AI）在泌尿肿瘤学领域的发展和研究仍在迅速推进。在这篇综述中，我们讨论了 AI 的基础知识、按肿瘤分组（肾癌、前列腺癌和膀胱癌）应用 AI 以及 AI 在机器人泌尿外科手术中的应用。我们还讨论了正在开发的 AI 的未来应用及其对泌尿肿瘤学患者的益处。
